PubMed:8473495 / 683-882 JSONTXT

Annnotations TAB JSON ListView MergeView

    jnlpba-st-training

    {"project":"jnlpba-st-training","denotations":[{"id":"T15","span":{"begin":137,"end":150},"obj":"DNA"}],"text":"To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections."}

    pubmed-sentences-benchmark

    {"project":"pubmed-sentences-benchmark","denotations":[{"id":"S6","span":{"begin":0,"end":199},"obj":"Sentence"}],"text":"To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections."}

    genia-medco-coref

    {"project":"genia-medco-coref","denotations":[{"id":"C20","span":{"begin":181,"end":184},"obj":"NP"}],"text":"To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections."}

    GENIAcorpus

    {"project":"GENIAcorpus","denotations":[{"id":"T25","span":{"begin":137,"end":150},"obj":"DNA_domain_or_region"}],"text":"To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression, we used transient DNA transfections."}